O'Neill Institute  |  September 2, 2021

Read the Publication

PRE-EXPOSURE PROPHYLAXIS (PrEP) IS A CRITICAL COMPONENT OF COMPREHENSIVE HIV PREVENTION.

Achieving widespread and sustained use of PrEP by individuals for whom it is recommended is critical to preventing new HIV infections, providing both individual and public health benefits. As such, PrEP has the potential to protect communities from HIV infection and strengthen them with lifelong benefits. Delivering PrEP effectively, however, requires overcoming multiple obstacles, not the least of which is ensuring affordable and hassle-free access to PrEP medications and related care.

Read the Quick Take here. 

Related Projects

HIV Policy Project

Latest publications See All

Report

October 14, 2025

Charles Holmes Maggie Little, Ph.D.; Heidi Weimer, J.D., MPH, LL.M; Dylan Green, MPH; Alicia Patterson, Ph.D.; Jonathan Healey; Sydney Luken; Janet Tatenda Bhila; Aleny Couto, MD; Shona Dalal, PhD; Will Fleisher, PhD; Jen Gennai; Rayid Ghani; Peter Godfrey-Faussett; Melissa Goldstein, JD; Kathy Hageman, PhD, MPH; Nina Hasen, PhD; Micheal Ighodaro; Thoko Kalua, MBBS, MSc; Jennifer Miller, PhD; Yogan Pillay, PhD; Anton Pozniak, MD; Miriam Rabkin, MD, MPH; David Ribes, PhD; Lisa Singh, PhD